Last month Federal Health Minister and Federal Member for Farrer Sussan Ley announced Keytruda (also known as Pembrolizumab) would be available on the PBS from September 1st.
The inclusion means patients would now only pay about $38 for the drug opposed to $150,000 a year.
Dr Steer who is based at the Murray Valley Private Hospital is currently treating about ten patients from regional Victoria and southern New South Wales for advanced melanoma.
He is looking forward to patients being able to access the drug and agreed it was "revolutionary".
He said research clearly showed the benefits of using the new immune-based therapy drug as opposed to using traditional chemotherapy drugs.
To continue reading this article at ABC and listen to Oncologist Dr Christopher Steer speak about the PBS, click here.